The Ascendance of Microphysiological Systems to Solve the Drug Testing Dilemma

References

• Paul SM, Mytelka DS, Dunwiddie CT et al. How to improve R&D productivity: the pharmaceutical industry's grand challenge. Nat. Rev. Drug Discov. 9(3), 203–214 (2010).
   PubMed Web of Science ®Google Scholar
• DiMasi JA, Grabowski HG, Hansen RW. Innovation in the pharmaceutical industry: new estimates of R&D costs. J. Health Econ. 47, 20–33 (2016).
   PubMed Web of Science ®Google Scholar
• Hay M, Thomas DW, Craighead JL, Economides C, Rosenthal J. Clinical development success rates for investigational drugs. Nat. Biotechnol. 32(1), 40–51 (2014).
   PubMed Web of Science ®Google Scholar
• Waring MJ, Arrowsmith J, Leach AR et al. An analysis of the attrition of drug candidates from four major pharmaceutical companies. Nat. Rev. Drug Discov. 14(7), 475–486 (2015).
   PubMed Web of Science ®Google Scholar
• Cook D, Brown D, Alexander R et al. Lessons learned from the fate of AstraZeneca's drug pipeline: a five-dimensional framework. Nat. Rev. Drug Discov. 13(6), 419–431 (2014).
   PubMed Web of Science ®Google Scholar
• Kerbrat A, Ferré J-C, Fillatre P et al. Acute neurologic disorder from an inhibitor of fatty acid amide hydrolase. N. Engl. J. Med. 375(18), 1717–1725 (2016).
   PubMed Web of Science ®Google Scholar
• ANSM: Agence Nationale de Sécurité du Médicament. Report by the Temporary Specialist Scientific Committee (TSSC), “FAAH (Fatty Acid Amide Hydrolase)”, on the causes of the accident during a Phase 1 clinical trial in Rennes in January 2016 (2016). http://ansm.sante.fr/var/ansm_site/storage/original/application/744c7c6daf96b141bc9509e2f85c227e.pdf.
   Google Scholar
• Hartung T, Rovida C. Chemical regulators have overreached. Nature. 460(7259), 1080–1081 (2009).
   PubMed Web of Science ®Google Scholar
• Long G, Works J. Innovation in the biopharmaceutical pipeline: a multidimensional view (2013). www.analysisgroup.com/uploadedfiles/content/insights/publishing/2012_innovation_in_the_biopharmaceutical_pipeline.pdf.
   Google Scholar
• Horner MJ, Hinrichs MJ, Buss N. Safety assessment strategies and predictive safety of biopharmaceuticals and antibody drug conjugates. In: Drug discovery toxicology: From target assessment to translational biomarkers. Will Y, McDuffie JE, Olaharski AJ, Jeffy BD ( Eds). John Wiley & Sons Inc, 27–38 (2016).
   Google Scholar
• Coleman MD, O'Neil JD, Woehrling EK et al. A preliminary investigation into the impact of a pesticide combination on human neuronal and glial cell lines in vitro. PLoS ONE 7(8), e42768 (2012).
   PubMed Web of Science ®Google Scholar
• Griesinger C, Desprez B, Coecke S, Casey W, Zuang V. Validation of alternative in vitro methods to animal testing: concepts, challenges, processes and tools. In: Advances In Experimental Medicine And Biology. Eskes C, Whelan M ( Eds). Springer International Publishing, 65–132 (2016).
   Google Scholar
• Hackam DG, Redelmeier DA. Translation of research evidence from animals to humans. JAMA 296(14), 1727–1732 (2006).
   Web of Science ®Google Scholar
• Seok J, Warren HS, Cuenca AG et al. Genomic responses in mouse models poorly mimic human inflammatory diseases. Proc. Natl Acad. Sci. USA 110(9), 3507–3512 (2013).
   PubMed Web of Science ®Google Scholar
• van der Worp HB, Howells DW, Sena ES et al. Can animal models of disease reliably inform human studies? PLoS Med. 7(3), e1000245 (2010).
   PubMed Web of Science ®Google Scholar
• Leist M, Hartung T. Inflammatory findings on species extrapolations: humans are definitely no 70-kg mice. Arch. Toxicol. 87(4), 563–567 (2013).
   PubMed Web of Science ®Google Scholar
• Greek R, Menache A. Systematic reviews of animal models: methodology versus epistemology. Int. J. Med. Sci. 10(3), 206–221 (2013).
   PubMed Web of Science ®Google Scholar
• Hartung T. Per aspirin ad astra. Altern. Lab. Anim. 37(Suppl. 2), 45–47 (2009).
   PubMedGoogle Scholar
• Woosley RL. Mechanism of the cardiotoxic actions of terfenadine. JAMA 269(12), 1532 (1993).
   PubMed Web of Science ®Google Scholar
• EU: European Union. Regulation (EC) No 1223/2009 of the European Parliament and of the Council of 30 November 2009 on cosmetic products (2009).
   Google Scholar
• ECHA: European Chemicals Agency. The use of alternatives to testing on animals for the REACH regulation. Helsinki (2014). https://echa.europa.eu/about-us/the-way-we-work/plans-and-reports.
   Google Scholar
• Westein E, van der Meer AD, Kuijpers MJE, Frimat J-P, van den Berg A, Heemskerk JWM. Atherosclerotic geometries exacerbate pathological thrombus formation poststenosis in a von Willebrand factor-dependent manner. Proc. Natl Acad. Sci. USA. 110(4), 1357–1362 (2013).
   PubMed Web of Science ®Google Scholar
• Maschmeyer I, Lorenz AK, Schimek K et al. A four-organ-chip for interconnected long-term co-culture of human intestine, liver, skin and kidney equivalents. Lab. Chip. 15(12), 2688–2699 (2015).
   PubMed Web of Science ®Google Scholar
• Huh D, Matthews BD, Mammoto A, Montoya-Zavala M, Hsin HY, Ingber DE. Reconstituting organ-level lung functions on a chip. Science. 328(5986), 1662–1668 (2010).
   PubMed Web of Science ®Google Scholar
• Maidhof R, Tandon N, Lee EJ et al. Biomimetic perfusion and electrical stimulation applied in concert improved the assembly of engineered cardiac tissue. J. Tissue Eng. Regen. Med. 6(10), e12–e23 (2012).
   PubMed Web of Science ®Google Scholar
• Harink B, Le Gac S, Truckenmüller R, van Blitterswijk C, Habibovic P. Regeneration-on-a-chip? The perspectives on use of microfluidics in regenerative medicine. Lab. Chip. 13(18), 3512–3528 (2013).
   PubMed Web of Science ®Google Scholar
• Pörtner R, Giese C. An overview on bioreactor design, prototyping and process control for reproducible three-dimensional tissue culture. In: Drug Testing In Vitro: Breakthroughs and Trends in Cell Culture Technology. Marx U, Sandig V ( Eds). Wiley-VCH, 3, 53–78 (2006).
   Google Scholar
• Marx U, Walles H, Hoffmann S et al. “Human-on-a-chip” developments: a translational cutting-edge alternative to systemic safety assessment and efficiency evaluation of substances in laboratory animals and man? Altern. Lab. Anim. 40(5), 235–257 (2012).
   PubMed Web of Science ®Google Scholar
• Grist SM, Schmok JC, Liu MC, Chrostowski L, Cheung KC. Designing a microfluidic device with integrated ratiometric oxygen sensors for the long-term control and monitoring of chronic and cyclic hypoxia. Sensors (Basel) 15(8), 20030–20052 (2015).
   PubMed Web of Science ®Google Scholar
• Ochs CJ, Kasuya J, Liebsch G. au2D-Visualisierung des zellulären Sauerstoff verbrauchs in Mikrofluidiksystemen. BIOspektrum 20(7), 773–775 (2014).
   Google Scholar
• Wagner I, Materne E-M, Marx U et al. A dynamic multi-organ-chip for long-term cultivation and substance testing proven by 3D human liver and skin tissue co-culture. Lab Chip 13(18), 3538–3547 (2013).
   PubMed Web of Science ®Google Scholar
• Powers MJ, Domansky K, Kaazempur-mofrad MR et al. A microfabricated array bioreactor for perfused 3D liver culture. Biotechnol. Bioeng. 78(3), 257–269 (2002).
   PubMed Web of Science ®Google Scholar
• Sin A, Baxter GT, Shuler ML. Animal on a chip: a microscale cell culture analog device for evaluating toxicological and pharmacological profiles. Microfluid. BioMEMS 4560, 98–101 (2001).
   Google Scholar
• Marx U, Andersson TB, Bahinski A, Beilmann M, Beken S, Cassee FR. Biology-inspired microphysiological system approaches to solve the prediction dilemma of substance testing. ALTEX 33(3), 272–321 (2016).
   PubMedGoogle Scholar
• Hung PJ, Lee PJ, Sabounchi P, Lin R, Lee LP. Continuous perfusion microfluidic cell culture array for high-throughput cell-based assays. Biotechnol. Bioeng. 89(1), 1–8 (2005).
   PubMed Web of Science ®Google Scholar
• Zhang MY, Lee PJ, Hung PJ, Johnson T, Lee LP, Mofrad MRK. Microfluidic environment for high density hepatocyte culture. Biomed. Microdevices 10(1), 117–121 (2008).
   PubMed Web of Science ®Google Scholar
• Sivaraman A, Leach JK, Townsend S et al. A microscale in vitro physiological model of the liver: predictive screens for drug metabolism and enzyme induction. Curr. Drug Metab. 6(6), 569–591 (2005).
   PubMed Web of Science ®Google Scholar
• Gordon S, Daneshian M, Bouwstra J et al. Non-animal models of epithelial barriers (skin, intestine and lung) in research, industrial applications and regulatory toxicology. ALTEX 32(4), 327–378 (2015).
   PubMedGoogle Scholar
• Benam KH, Villenave R, Lucchesi C et al. Small airway-on-a-chip enables analysis of human lung inflammation and drug responses in vitro. Nat. Methods 13(2), 151–157 (2016).
   PubMed Web of Science ®Google Scholar
• Jan K-J, Mehr AP, Hamilton GA et al. Human kidney proximal tubule-on-a-chip for drug transport and nephrotoxicity assessment. Integr. Biol. 5(9), 1119–1129 (2013).
   Google Scholar
• Korin N, Kanapathipillai M, Matthews BD et al. Shear-activated nanotherapeutics for drug targeting to obstructed blood vessels. Science 337(6095), 738–742 (2012).
   PubMed Web of Science ®Google Scholar
• Jain A, van der Meer AD, Papa A-L et al. Assessment of whole blood thrombosis in a microfluidic device lined by fixed human endothelium. Biomed. Microdevices 18(4), 73 (2016).
   PubMed Web of Science ®Google Scholar
• Torisawa Y, Spina CS, Mammoto T et al. Bone marrow-on–a-chip replicates hematopoietic niche physiology in vitro. Nat. Methods 11(6), 663–669 (2014).
   PubMed Web of Science ®Google Scholar
• Kim HJ, Huh D, Hamilton G, Ingber DE. Human gut-on-a-chip inhabited by microbial flora that experiences intestinal peristalsis-like motions and flow. Lab Chip. 12, 2165–2174 (2012).
   PubMed Web of Science ®Google Scholar
• Trietsch JS, Israëls G, Joore J, Hankemeier T, Vulto P. Microfluidic titer plate for stratified 3D cell culture. Lab Chip 13, 3548–3554 (2013).
   PubMed Web of Science ®Google Scholar
• Wevers NR, Van Vught R, Wilschut KJ et al. High-throughput compound evaluation on 3D networks of neurons and glia in a microfluidic platform. Sci. Rep. 6, 1–10 (2016).
   PubMed Web of Science ®Google Scholar
• Kim J, Fluri DA, Kelm JM, Hierlemann A, Frey O. 96-well format-based microfluidic platform for parallel interconnection of multiple multicellular spheroids. J. Lab. Autom. 20(3), 274–282 (2015).
   PubMedGoogle Scholar
• Kim J-Y, Fluri DA, Marchan R et al. 3D spherical microtissues and microfluidic technology for multi-tissue experiments and analysis. J. Biotechnol. 205, 24–35 (2015).
   PubMed Web of Science ®Google Scholar
• Kelm JM, Fussenegger M. Microscale tissue engineering using gravity-enforced cell assembly. Trends Biotechnol. 22(4), 195–202 (2004).
   PubMed Web of Science ®Google Scholar
• Messner S, Agarkova I, Moritz W, Kelm JM. Multi-cell type human liver microtissues for hepatotoxicity testing. Arch. Toxicol. 87(1), 209–213 (2013).
   PubMed Web of Science ®Google Scholar
• Frey O, Misun PM, Fluri DA, Hengstler JG, Hierlemann A. Reconfigurable microfluidic hanging drop network for multi-tissue interaction and analysis. Nat. Commun. 5, 1–11 (2014).
   Web of Science ®Google Scholar
• Viravaidya K, Shuler ML. Incorporation of 3T3-L1 cells to mimic bioaccumulation in a microscale cell culture analog device for toxicity studies. Biotechnol. Prog. 20(2), 590–597 (2004).
   PubMed Web of Science ®Google Scholar
• Oleaga C, Bernabini C, Smith AST et al. Multi-organ toxicity demonstration in a functional human in vitro system composed of four organs. Sci. Rep. 6, 1–17 (2016).
   PubMed Web of Science ®Google Scholar
• Viravaidya K, Sin A, Shuler ML. Development of a microscale cell culture analog to probe naphthalene toxicity. Biotechnol. Prog. 20(1), 316–323 (2004).
   PubMed Web of Science ®Google Scholar
• Tatosian Da, Shuler ML. A novel system for evaluation of drug mixtures for potential efficacy in treating multidrug resistant cancers. Biotechnol. Bioeng. 103(1), 187–198 (2009).
   PubMed Web of Science ®Google Scholar
• Miller PG, Shuler ML. Design and demonstration of a pumpless 14 compartment microphysiological system. Biotechnol. Bioeng. 113(10), 2213–2227 (2016).
   PubMed Web of Science ®Google Scholar
• Ding B-S, Nolan DJ, Butler JM et al. Inductive angiocrine signals from sinusoidal endothelium are required for liver regeneration. Nature 468(7321), 310–315 (2010).
   PubMed Web of Science ®Google Scholar
• Schimek K, Busek M, Brincker S et al. Integrating biological vasculature into a multi-organ-chip microsystem. Lab Chip. 13(18), 3588–3598 (2013).
   PubMed Web of Science ®Google Scholar
• Hasenberg T, Mühleder S, Dotzler A et al. Emulating human microcapillaries in a multi-organ-chip platform. J. Biotechnol. 216, 1–10 (2015).
   PubMed Web of Science ®Google Scholar
• Hughes P, Marshall D, Reid Y, Parkes H, Gelber C. The costs of using unauthenticated, over-passaged cell lines: how much more data do we need? Biotechniques 43(5), 575, 577–578, 581–582 passim (2007).
   Web of Science ®Google Scholar
• Kleensang A, Vantangoli MM, Odwin-DaCosta S et al. Genetic variability in a frozen batch of MCF-7 cells invisible in routine authentication affecting cell function. Sci. Rep. 6, 28994 (2016).
   PubMed Web of Science ®Google Scholar
• Olarerin-George AO, Hogenesch JB. Assessing the prevalence of mycoplasma contamination in cell culture via a survey of NCBI's RNA-seq archive. Nucleic Acids Res. 43(5), 2535–2542 (2015).
   PubMed Web of Science ®Google Scholar
• Tolosa L, Gómez-Lechón MJ, López S et al. Human upcyte hepatocytes: characterization of the hepatic phenotype and evaluation for acute and long-term hepatotoxicity routine testing. Toxicol. Sci. 152(1), 214–229 (2016).
   PubMed Web of Science ®Google Scholar
• Schaefer M, Schänzle G, Bischoff D, Süssmuth RD. Upcyte human hepatocytes: a potent in vitro tool for the prediction of hepatic clearance of metabolically stable compounds. Drug Metab. Dispos. 44(3), 435–444 (2016).
   PubMed Web of Science ®Google Scholar
• Lipps C, May T, Hauser H, Wirth D. Eternity and functionality – rational access to physiologically relevant cell lines. Biol. Chem. 394(12), 1637–1648 (2013).
   PubMed Web of Science ®Google Scholar
• Ramachandran SD, Schirmer K, Münst B et al. In vitro generation of functional liver organoid-like structures using adult human cells. PLoS ONE 10(10), e0139345 (2015).
   PubMed Web of Science ®Google Scholar
• Bellin M, Marchetto MC, Gage FH, Mummery CL. Induced pluripotent stem cells: the new patient? Nat. Rev. Mol. Cell Biol. 13(11), 713–726 (2012).
   PubMed Web of Science ®Google Scholar
• Maschmeyer I, Hasenberg T, Jaenicke A et al. Chip-based human liver-intestine and liver-skin co-cultures – A first step toward systemic repeated dose substance testing in vitro. Eur. J. Pharm. Biopharm. 95, 77–87 (2015).
   PubMed Web of Science ®Google Scholar
• van Midwoud PM, Janse A, Merema MT, Groothuis GMM, Verpoorte E. Comparison of biocompatibility and adsorption properties of different plastics for advanced microfluidic cell and tissue culture models. Anal. Chem. 84(9), 3938–3944 (2012).
   PubMed Web of Science ®Google Scholar
• Emulate I. Collaboration with J&J Innovation – Emulate, Inc (2015). https://emulatebio.com/press/strategic-collaboration/.
   Google Scholar
• CN Bio Innovations. CN Bio Innovations marks World Hepatitis Day by signing research agreement with Imperial College London (2014). http://cn-bio.com/cn-bio-innovations-marks-world-hepatitis-day-signing-research-agreement-imperial-college-london/.
   Google Scholar
• TissUse GmbH. Multi-organ-chips revolutionize drug testing (2014). www.tissuse.com/en/news/press-releases/.
   Google Scholar
• EMA: European Medicines Agency. Draft guideline on regulatory acceptance of 3Rs (Replacement, Reduction, Refinement) testing approaches. www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2014/10/WC500174977.pdf.
   Google Scholar
• Pamies D, Bal-Price A, Simeonov A et al. Good cell culture practice for stem cells and stem-cell-derived models. ALTEX. doi:10.14573/altex.1607121 (2016) ( Epub ahead of print).
   Google Scholar
• Horvath P, Aulner N, Bickle M et al. Screening out irrelevant cell-based models of disease. Nat. Rev. Drug Discov. 15(11), 751–769 (2016).
   PubMed Web of Science ®Google Scholar
• OECD: Organisation for Economic Co-operation and Development. Guidance document on the validation and international acceptance of new or updated test methods for hazard assessment. No. 34, 1–96 (2005). www.oecd.org/chemicalsafety/testing/seriesontestingandassessmentpublicationsbynumber.htm.
   Google Scholar
• US-Congress. The Frank R. Lautenberg chemical safety for the 21st century act (2016). www.epa.gov/assessing-and-managing-chemicals-under-tsca/frank-r-lautenberg-chemical-safety-21st-century-act.
   Google Scholar
• Wang B, Gray G. Concordance of noncarcinogenic endpoints in rodent chemical bioassays. Risk Anal. 35(6), 1154–1166 (2015).
   PubMed Web of Science ®Google Scholar
• Luechtefeld T, Maertens A, Russo DP, Rovida C, Zhu H, Hartung T. Analysis of publically available skin sensitization data from REACH registrations 2008-2014. ALTEX 33(2), 135–148 (2016).
   PubMedGoogle Scholar
• Luechtefeld T, Maertens A, Russo DP, Rovida C, Zhu H, Hartung T. Analysis of Draize eye irritation testing and its prediction by mining publicly available 2008-2014 REACH data. ALTEX 33(2), 123–134 (2016).
   PubMedGoogle Scholar
• OECD: Organisation for Economic Co-operation and Development. Test No. 429: Skin Sensitisation (2016). www.oecd-ilibrary.org/content/book/9789264071100-en.
   Google Scholar
• Browne P, Judson RS, Casey WM, Kleinstreuer NC, Thomas RS. Screening chemicals for estrogen receptor bioactivity using a computational model. Environ. Sci. Technol. 49(14), 8804–8814 (2015).
   PubMed Web of Science ®Google Scholar
• Murphy SV, Atala A. 3D bioprinting of tissues and organs. Nat. Biotechnol. 32(8), 773–785 (2014).
   PubMed Web of Science ®Google Scholar
• Ahadian S, Ramón-Azcón J, Ostrovidov S et al. Interdigitated array of Pt electrodes for electrical stimulation and engineering of aligned muscle tissue. Lab Chip. 12(18), 3491–3503 (2012).
   PubMed Web of Science ®Google Scholar
• Johnstone AFM, Gross GW, Weiss DG, Schroeder OH-U, Gramowski A, Shafer TJ. Microelectrode arrays: a physiologically based neurotoxicity testing platform for the 21st century. Neurotoxicology 31(4), 331–350 (2010).
   PubMed Web of Science ®Google Scholar
• Ferrell N, Desai RR, Fleischman AJ, Roy S, Humes HD, Fissell WH. A microfluidic bioreactor with integrated transepithelial electrical resistance (TEER) measurement electrodes for evaluation of renal epithelial cells. Biotechnol. Bioeng. 107(4), 707–716 (2010).
   PubMed Web of Science ®Google Scholar
• Kim HJ, Huh D, Hamilton G, Ingber DE, Links DA. Human gut-on-a-chip inhabited by microbial flora that experiences intestinal peristalsis-like motions and flow. Lab Chip 12(12), 2165–2174 (2012).
   PubMed Web of Science ®Google Scholar
• Yu J, Peng S, Luo D, March JC. In vitro 3D human small intestinal villous model for drug permeability determination. Biotechnol. Bioeng. 109(9), 2173–2178 (2012).
   PubMed Web of Science ®Google Scholar
• Domansky K, Inman W, Serdy J, Dash A, Lim MHM, Griffith LG. Perfused multiwell plate for 3D liver tissue engineering. Lab Chip 10(1), 51–58 (2010).
   PubMed Web of Science ®Google Scholar